Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer

Clinical trial NCT06758700 · RECRUITING

Trial details

NCT number: NCT06758700
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive-stage Small Cell Lung Cancer (ES-SCLC)Thoracic Neoplasms Lung Neoplasms Lung Diseases

Start date: 2025-02-07
Primary completion: 2026-06-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.